|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 23, 2016 ) Executive Summary
Irritable Bowel Syndrome or IBS is a gastrointestinal disorder in which the colon muscle contracts more readily. The high prevalence of this syndrome could be estimated from the fact that 1 out of every 5 American is affected by the disorder and it is more common in women. Though the exact cause of the disorder is still unknown, factors like food, medicine, lifestyle and emotional stress can trigger the condition.
The global IBS market holds immense business opportunities as there are very few drugs and treatment available in the market. Moreover, only about 60% of the patient suffering from the syndrome tends to seek medical aid. The market is characterized with high unmet demand for proper treatment and this has resulted in many ongoing research and clinical trials. At present Amitiza and Lotronex are the only FDA approved drugs available in the market, which has created a necessity for more drugs and therapies in the Irritable Bowel Syndrome market. The IBS market is likely to witness arrival of many other drugs and first class therapies in the foreseeable future leading to generic competition in the market.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=186810
Scope of the Report
The report titled ‘Global Irritable Bowel Syndrome Market: Trends and Opportunities (2012-17)’ provides an in depth analysis of IBS market on a global level. The report presents the global market sizing of IBS and also predicts the future growth of the market. The report also analyzes the various sub segments of the market and the worldwide sales of drugs available for the specific segment. Besides presenting the competitive landscape, the report also assesses the growth of IBS market in United States, Japan, and the United Kingdom. It also includes the penetration rate of the disorder in Germany, France, Italy, Spain and Belgium. In addition, the report focuses on the various growth drivers and challenges faced by the Irritable Bowel Syndrome (IBS) market.
Geographical Coverage
United States
Market Size
Laxatives market growth projections
Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Content
1. Executive Summary
2. Global Irritable Bowel Syndrome (IBS) Market: An Analysis
2.1. IBS Market Sizing and Growth (Actual and Forecast, by value)
2.2. IBS Market: Segment Analysis
2.2.1. IBS-D (Worldwide Sales and Competitive Landscape)
2.2.2. IBS-C (Worldwide Sales and Competitive Landscape)
3. Global Irritable Bowel Syndrome (IBS) Market: Geographical Analysis
3.1. United States
3.1.1. IBS Market Sizing and Growth (Actual and Forecast, by No. of Patients)
3.1.2. U.S. laxative market growth projections (Actual and Forecast, by value)
3.2. Japan
3.2.1. IBS Market Sizing and Growth (Actual and Forecast, by No. of Patients)
3.2.2. Prevalence Based on Subtype (Gender and Age)
3.3. European Union
3.3.1. IBS Market Sizing and Growth (Actual and Forecast, by No. of Patients)
3.3.2. Country-wise Analysis (Based on Penetration rate)
4. Porters Five Forces Analysis
5. Growth Drivers
6. Challenges
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
